Results 51 to 60 of about 3,878,916 (126)

Fixed drug eruption – A retrospective review of 146 patients in a tertiary hospital in Southern Taiwan

open access: yesDermatologica Sinica
In this retrospective study, the clinical characteristics of 146 patients diagnosed with fixed drug eruption (FDE) in a tertiary hospital in Southern Taiwan were analyzed.
Jui-Wen Yeh, Wei-Ting Liu
doaj   +1 more source

European Society of Contact Dermatitis Guideline for Diagnostic Patch Testing—Recommendations on Best Practice (Update 2026)

open access: yesContact Dermatitis, Volume 95, Issue 3, Page 237-275, September 2026.
ABSTRACT The present guideline updates the initial ESCD patch testing guideline, summarizing all aspects of patch testing for the diagnosis of contact allergy in patients suspected of suffering, or having been suffering, from allergic contact dermatitis or other delayed‐type hypersensitivity skin and mucosal conditions. Sections with brief descriptions
Wolfgang Uter   +23 more
wiley   +1 more source

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 7, Page 1137-1161, July 2026.
Autoimmune blistering disorders (AIBDs) in children are rare, challenging to diagnose and treat and often require immunosuppressants. Until now, no paediatric care guidelines existed. The EADV Task Force for AIBDs has developed the consensus‐based recommendations, enabling physicians to adopt a uniform, tailored treatment strategy to improve outcomes ...
A. Nanda   +31 more
wiley   +1 more source

Generalized fixed drug eruption to piperacillin/tazobactam and review of literature [PDF]

open access: yes, 2018
Fixed drug eruption (FDE) is an adverse drug reaction characterized by the development of well-circumscribed, round, dusky erythematous macules and plaques on cutaneous or mucosal surfaces.
Konia, Thomas   +10 more
core   +1 more source

A Systematic Review of Literature: TNF‐α Blockers and JAK Inhibitors for the Treatment of Stevens‐Johnson Syndrome, Toxic Epidermal Necrolysis, and Severe Forms of Erythema Multiforme

open access: yesHealth Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Stevens‐Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), and erythema multiforme major (EM major) are severe dermatologic conditions characterized by varying degrees of skin detachment and involvement of mucosal membranes, often triggered by drug reactions or infections.
Sadaf Salehi   +6 more
wiley   +1 more source

Immunotherapy‐Related Cutaneous Toxicities in Melanoma: A Dermoscopic Perspective

open access: yesJEADV Clinical Practice, Volume 5, Issue 2, Page 402-414, June 2026.
Dermoscopy serves as a valuable tool in the everyday dermatological and oncological practice for melanoma patients, allowing for the prompt identification of immune‐related cutaneous toxicities and guiding clinicians toward appropriate therapeutic decisions.
Grażyna Kamińska‐Winciorek   +3 more
wiley   +1 more source

Two cases of generalized bullous fixed-drug eruption triggered by etodolac

open access: yesTurkderm Turkish Archives of Dermatology and Venereology, 2023
Işıl Göğem İmren   +5 more
doaj   +1 more source

Wells syndrome: clinical findings and treatment management in a large cohort of 48 patients

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 5, Page 644-656, May 2026.
Summary Background and Objectives: Wells syndrome (WS) is a rare inflammatory skin disorder typically characterized by erythematous, edematous, and pruritic plaques. Despite its distinct histopathological features, WS remains an underdiagnosed disease due to its variable clinical presentations and overlap with other dermatological conditions.
Marco Adriano Chessa   +8 more
wiley   +1 more source

A Multifaceted Holistic Review of the Literature on Scar Dermatoses

open access: yesInternational Wound Journal, Volume 23, Issue 5, May 2026.
ABSTRACT Many cutaneous diseases originate or manifest in scars. Scars are areas of compromised skin, which renders them a vulnerable cutaneous district for diseases to develop. The pathophysiology explaining why some dermatoses grow in scars is not yet thoroughly explored. The present study reviews the present literature on scar dermatoses.
Dana Maria Khoury   +5 more
wiley   +1 more source

A CASE OF TENOXICAM INDUCED GENERALIZED (MULTIFOCAL) BULLOUS FIXED DRUG ERUPTION

open access: yes, 2008
Fixed drug eruption is a common cutaneus reaction characterized by the formation of localized erytema, hyperpigmentation and blisters that recur at the same cutaneous site or sites each time when the drug is ingested. Rarely it can be disseminated. Fixed
Arican, Ozer, Urun, Mustafa
core   +1 more source

Home - About - Disclaimer - Privacy